Advanced

A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement

De Roos, Paul; Bloem, Bastiaan R.; Kelley, Thomas A.; Antonini, Angelo; Dodel, Richard; Hagell, Peter LU ; Marras, Connie; Martinez-Martin, Pablo; Mehta, Shyamal H. and Odin, Per LU , et al. (2017) In Journal of Parkinson's Disease 7(3). p.533-543
Abstract

Background: Parkinson's disease (PD) is a progressive neurodegenerative condition that is expected to double in prevalence due to demographic shifts. Value-based healthcare is a proposed strategy to improve outcomes and decrease costs. To move towards an actual value-based health care system, condition-specific outcomes that are meaningful to patients are essential. Objective: Propose a global consensus standard set of outcome measures for PD. Methods: Established methods for outcome measure development were applied, as outlined and used previously by the International Consortium for Health Outcomes Measurement (ICHOM). An international group, representing both patients and experts from the fields of neurology, psychiatry, nursing, and... (More)

Background: Parkinson's disease (PD) is a progressive neurodegenerative condition that is expected to double in prevalence due to demographic shifts. Value-based healthcare is a proposed strategy to improve outcomes and decrease costs. To move towards an actual value-based health care system, condition-specific outcomes that are meaningful to patients are essential. Objective: Propose a global consensus standard set of outcome measures for PD. Methods: Established methods for outcome measure development were applied, as outlined and used previously by the International Consortium for Health Outcomes Measurement (ICHOM). An international group, representing both patients and experts from the fields of neurology, psychiatry, nursing, and existing outcome measurement efforts, was convened. The group participated in six teleconferences over a six-month period, reviewed existing data and practices, and ultimately proposed a standard set of measures by which patients should be tracked, and how often data should be collected. Results: The standard set applies to all cases of idiopathic PD, and includes assessments of motor and non-motor symptoms, ability to work, PD-related health status, and hospital admissions. Baseline demographic and clinical variables are included to enable case mix adjustment. Conclusions: The Standard Set is now ready for use and pilot testing in the clinical setting. Ultimately, we believe that using the set of outcomes proposed here will allow clinicians and scientists across the world to document, report, and compare PD-related outcomes in a standardized fashion. Such international benchmarks will improve our understanding of the disease course and allow for identification of 'best practices', ultimately leading to better informed treatment decisions.

(Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Parkinson's Disease
volume
7
issue
3
pages
11 pages
publisher
IOS Press
external identifiers
  • scopus:85027410213
ISSN
1877-7171
DOI
10.3233/JPD-161055
language
English
LU publication?
no
id
337cd8ff-989e-491d-9249-41577f60dedf
date added to LUP
2017-09-04 17:15:01
date last changed
2018-03-25 04:39:28
@article{337cd8ff-989e-491d-9249-41577f60dedf,
  abstract     = {<p>Background: Parkinson's disease (PD) is a progressive neurodegenerative condition that is expected to double in prevalence due to demographic shifts. Value-based healthcare is a proposed strategy to improve outcomes and decrease costs. To move towards an actual value-based health care system, condition-specific outcomes that are meaningful to patients are essential. Objective: Propose a global consensus standard set of outcome measures for PD. Methods: Established methods for outcome measure development were applied, as outlined and used previously by the International Consortium for Health Outcomes Measurement (ICHOM). An international group, representing both patients and experts from the fields of neurology, psychiatry, nursing, and existing outcome measurement efforts, was convened. The group participated in six teleconferences over a six-month period, reviewed existing data and practices, and ultimately proposed a standard set of measures by which patients should be tracked, and how often data should be collected. Results: The standard set applies to all cases of idiopathic PD, and includes assessments of motor and non-motor symptoms, ability to work, PD-related health status, and hospital admissions. Baseline demographic and clinical variables are included to enable case mix adjustment. Conclusions: The Standard Set is now ready for use and pilot testing in the clinical setting. Ultimately, we believe that using the set of outcomes proposed here will allow clinicians and scientists across the world to document, report, and compare PD-related outcomes in a standardized fashion. Such international benchmarks will improve our understanding of the disease course and allow for identification of 'best practices', ultimately leading to better informed treatment decisions.</p>},
  author       = {De Roos, Paul and Bloem, Bastiaan R. and Kelley, Thomas A. and Antonini, Angelo and Dodel, Richard and Hagell, Peter and Marras, Connie and Martinez-Martin, Pablo and Mehta, Shyamal H. and Odin, Per and Chaudhuri, Kallol Ray and Weintraub, Daniel and Wilson, Bil and Uitti, Ryan J.},
  issn         = {1877-7171},
  language     = {eng},
  number       = {3},
  pages        = {533--543},
  publisher    = {IOS Press},
  series       = {Journal of Parkinson's Disease},
  title        = {A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement},
  url          = {http://dx.doi.org/10.3233/JPD-161055},
  volume       = {7},
  year         = {2017},
}